Skip to site alert.
Skip to content
Showing 41 - 50 of 238 results.
This past August, after a two-year hiatus, Project Medical Education (PME) returned to Columbia University Irving Medical Center (CUIMC).
We provide a rich resource for dissecting the regulatory network that governs the developmental potency of EPSCs and exploring alternative strategies to capture totipotent stem cells in culture.
The Cancer Discovery Research award provides recipients with funding at $200,000 per year for up to three years.
Aaron Viny, MD, assistant professor of medicine at VP&S, joins 16 recipients recognized for research that has the potential to advance the prevention, diagnosis and treatment of human disease.
Here we describe a method for spatially resolved chromatin accessibility profiling of tissue sections using next-generation sequencing.
Discovery of the CRISPR-associated protein Cas9 and its RNA-guided cleavage mechanism marks the beginning of a new era in genomic engineering by enabling the editing of a target region in the genome.
Our results uncover a unifying stress-response pathway causally linking Aβ42o-dependent structural remodeling of dendritic mitochondria to synaptic loss.
Today Hynek Wichterle, PhD, and his colleagues are tantalizingly close to bringing a new drug for amyotrophic lateral sclerosis (ALS) to market.
The findings provide new insights into the basic biology of human reproduction and in the long term could lead to improvements in the success rate of in vitro fertilization (IVF).
Researchers have found that most of these mistakes are due to spontaneous errors in DNA replication in the earliest phase of cell division.